Pricing Log in Create free account

MedX Health Corp. (MDXHF) vs Exagen Inc. (XGN)

MedX Health Corp. and Exagen Inc. are both Diagnostics & Research companies. Exagen Inc. is the larger, with a market value of $184.1M against $103.2M — 1.8× the size. Exagen Inc. grew revenue faster over the last twelve months: 20.8% against 20.1%. Exagen Inc. has the higher net margin (−26.6% vs −1,087.8%) and the lower return on invested capital (−68.3% vs 0.00%). Across the 17 metrics below, Exagen Inc. leads on 13 and MedX Health Corp. on 4.

Valuation

Metric MDXHF XGN Diagnostics & Research median
P/E n/m n/m 34.52
P/S 23.85 2.56 4.24
P/B n/m 14.88 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 29.40 2.55 5.18
Earnings yield (46.67%) (10.77%) (1.50%)
Free cash flow yield (52.97%) (4.17%) 0.00%

Profitability

Metric MDXHF XGN Diagnostics & Research median
Gross margin (1.89%) 58.64% 48.32%
Operating margin (753.38%) (18.58%) (5.68%)
Net margin (1,087.83%) (26.61%) (4.10%)
Free cash flow margin (655.93%) (10.66%) 0.00%
Return on equity 63.71% (113.82%) 0.00%
Return on assets (840.71%) (34.19%) (6.05%)
Return on invested capital 0.00% (68.33%) 0.00%

Growth

Metric MDXHF XGN Diagnostics & Research median
Revenue growth (TTM) 20.12% 20.83% 8.99%
EPS growth (last fiscal year) (52.00%) (12.05%) 20.36%
Revenue growth, 5-year CAGR (55.05%) 9.66% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDXHF XGN Diagnostics & Research median
Debt to equity (0.30) 2.00 0.01
Current ratio 0.02 3.18 2.27
Net debt to EBITDA (0.40) 0.68 0.68

Dividend

Metric MDXHF XGN Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric MDXHF XGN Diagnostics & Research median
Market cap 103.16m 184.11m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack